Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
Authors:
- Linda M. MeyerLMLinda M. Meyer
- Carl-Ludwig SchönfeldCSCarl-Ludwig Schönfeld
Open Access
- 1 January 2011
- journal article
- Published by S. Karger AG in Case Reports in Ophthalmology
- Vol. 2 (3) , 319-322
Abstract
Purpose: To report the effective treatment of cystoid macular edema (CME) following complicated cataract surgery (resulting in Irvine-Gass syndrome) with a dexamethasone 0.7-mg (Ozurdex®) intravitreal implant. Methods: An interventional case report with optical coherence tomography (OCT) scans. Results: An 83-year-old Caucasian woman was suffering from CME following complicated cataract surgery on her left eye. She had undergone 3 intravitreal injections of dexamethasone 0.4 mg in the 3 months following the surgery without any improvement of visual function. Seven months after the cataract surgery, she received a single intravitreal injection of dexamethasone 0.7 mg (Ozurdex). Four weeks following the injection, her best-corrected visual acuity improved from 0.3 to 0.8. CME resolved with a reduction of central retinal thickness from 393 µm pre-Ozurdex injection to 212 µm post-Ozurdex injection, as measured by OCT scan. Conclusion: Dexamethasone 0.7 mg (Ozurdex) has proven to be an effective treatment option in retinal vein occlusion and non-infectious uveitis. It can also be considered as off-label treatment in Irvine-Gass syndrome.Keywords
This publication has 9 references indexed in Scilit:
- Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior UveitisArchives of Ophthalmology (1950), 2011
- Clinical applications of the sustained-release dexamethasone implant for treatment of macular edemaClinical Ophthalmology, 2011
- Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal ImplantInvestigative Ophthalmology & Visual Science, 2011
- PHARMACOLOGIC THERAPY OF PSEUDOPHAKIC CYSTOID MACULAR EDEMARetina, 2011
- Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein OcclusionOphthalmology, 2010
- Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular EdemaOphthalmology, 2009
- Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass SyndromeAmerican Journal of Ophthalmology, 2009
- Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic reviewBritish Journal of Ophthalmology, 2005
- Causes of decreased visual acuity after cataract extractionJournal of Cataract & Refractive Surgery, 1995